EB138 January 2016

Posted Thu, 2015-06-18 08:17

The 138th Executive Board meeting of the World Health Organisation took place from 25 to 30 January 2016 in Geneva. The People's Health Movement intervened in the meeting through its WHO Watch Initiative. PHM has prepared an Integrated Commentary (as of 23 January 2016) as well as a compilation of 4 Policy Briefs and 12 Statements from the floor.

You can find all the Statements below:

  • 5.3 Framework of engagement with non-State actors: text, video, interview
  • 6.1 Maternal, infant and young child nutrition: text, video, interview
  • 6.2 Draft global plan of action on violence: text, video, interview
  • 6.3 Prevention and control of noncommunicable diseases: text, video, interview
  • 6.5 United Nations Decade of Action for Road Safety: text, video, interview
  • 7.5 Response to the adverse health effects of air pollution: text, video, interview
  • 9.1 Ebola virus disease outbreak and issues raised: text, video, interview.
  • 9.3 Global vaccine action plan: text, video, interview
  • 10.1 Health workforce and services: text, video, interview
  • 10.2 Comprehensive evaluation of the GSPOA: text, video, interview.
  • 10.3 Follow-up to the report of the CEWG: text, video, interview.
  • 10.4 SSFFC medical products: text, video, interview
  • 10.5 Addressing the global shortages of medicines: text, video, interview

You can find the watchers analysis of the Director General's Opening Address here and an Open Letter on the Framework of Engagement with Non-State Actors here.

This year's watchers team includes Alexandre Gajardo (UAEM, Switzerland), Julia Montana Lopez (UAEM, Spain), Julie Steendam (M3M, Belgium), Kingsley Pereko (PHM, Ghana), Lauren Chan (UAEM, Canada), Mai Seida (PHM, Egypte), Susana Barria (PHM, India), Susanna Bolchini (PHM, Italy). Kamil McClelland, Manuel Martin and Matt Quinn from UAEM UK also took part in the preparatory workshop, along with Amit Sengupta (PHM, India) and David Legge (PHM, Australia).

You can find the official WHO document on the WHO web page here: WHO documents EB138.

 

Agenda of the EB 138

1. Opening of the session and adoption of the agenda (EB138/1 Rev.1, EB138/1 annotated)

2. Report by the Director-General (EB138/2)

3. Report of the PBAC (EB138/3) PHM Comment

4. Report of the regional committees to the Executive Board (EB138/4) PHM Comment

5. WHO reform

5.1 Overview of reform implementation (EB138/5) PHM Comment

5.2 Member State consultative process on governance reform (EB138/6) PHM Comment

5.3 Framework of engagement with non-State actors (EB138/7) PHM Comment

6. Noncommunicable diseases

6.1 Maternal, infant and young child nutrition (EB138/8) PHM Comment

6.2 Draft global plan of action on violence (EB138/9) PHM Comment

6.3 Prevention and control of noncommunicable diseases: responses to specific assignments in preparation for the third High-level Meeting of the United Nations General Assembly on the Prevention and Control of Non-communicable diseases in 2018 (EB138/10) PHM Comment

6.4 Public health dimension of the world drug problem including in the context of the Special Session of the United Nations General Assembly on the World Drug Problem, to be held in 2016 (EB138/11) PHM Comment

6.5 Addressing the challenges of the United Nations Decade of Action for Road Safety (2011‒2020): outcome of the Second Global High-level Conference on Road Safety – Time for Results (EB138/12) PHM Comment

7. Promoting health through the life course

7.1 Monitoring of the achievement of the health-related Millennium Development Goals (EB138/13) PHM Comment

7.2 Health in the 2030 Agenda for Sustainable Development (EB138/14) PHM Comment

7.3 Operational plan to take forward the Global Strategy on Women’s, Children’s and Adolescents’ Health (EB138/15) PHM Comment

7.4 Multisectoral action for a life course approach to healthy ageing: draft global strategy and plan of action on ageing and health (EB138/16) PHM Comment

7.5 Health and the environment: draft roadmap for an enhanced global response to the adverse health effects of air pollution (EB138/17) PHM Comment

7.6 Role of the health sector in the sound management of chemicals (EB138/18) PHM Comment

8. Preparedness, surveillance and response

8.1 Implementation of the International Health Regulations (2005) (EB138/19) PHM Comment

  • Report of the First Meeting of the Review Committee on the Role of the International Health Regulations (2005) in the Ebola Outbreak and Response (EB138/20) PHM Comment

8.2 Pandemic influenza preparedness: sharing of influenza viruses and access to vaccines and other benefits (EB138/21, EB138/21 Add.1) PHM Comment

8.3 Smallpox eradication: destruction of variola virus stocks (EB138/22) PHM Comment

8.4 WHO response in severe, large-scale emergencies (EB138/23) PHM Comment

8.5 Global action plan on antimicrobial resistance (EB138/24) PHM Comment

8.6 Poliomyelitis (EB138/25) PHM Comment

8.7 Promoting the health of migrants (EB138/26) PHM Comment

9. Communicable diseases

9.1 2014 Ebola virus disease outbreak and issues raised: follow-up to the Special Session of the Executive Board on the Ebola Emergency (resolution EBSS3.R1) and the Sixty-eighth World Health Assembly (decision WHA68(10))

  • 9.1A: Update on 2014 Ebola virus disease outbreak and Secretariat response to other issues raised (EB138/27) PHM Comment

  • 9.1B: Options for strengthening information-sharing on diagnostic, preventive and therapeutic products and for enhancing WHO’s capacity to facilitate access to these products, including the establishment of a global database, starting with haemorrhagic fevers (EB138/28) PHM Comment

9.2 Draft global health sector strategies

9.3 Global vaccine action plan (EB138/32) PHM Comment

9.4 Mycetoma (EB138/33) PHM Comment

10. Health systems

10.1 Health workforce and services (EB138/34, EB138/35) PHM Comment

  • 10.1B. Draft global strategy on human resources for health: workforce 2030 (EB138/36) PHM Comment

10.2 Comprehensive evaluation of the global strategy and plan of action on public health, innovation and intellectual property: progress update (EB138/38, EB138/38 Add.1) PHM Comment

10.3 Follow-up to the report of the Consultative Expert Working Group on Research and Development: Financing and Coordination ‒ Planning for an open-ended meeting of Member States to discuss progress (EB138/39) PHM Comment

10.4 Substandard/spurious/falsely-labelled/falsified/counterfeit medical products (EB138/40) PHM Comment

10.5 Addressing the global shortages of medicines, and the safety and accessibility of children’s medication (EB138/41) PHM Comment

11. Financial matters

11.1 Financing of Programme budget 2016–2017 (EB138/42) PHM Comment

11.2 Scale of assessments (EB138/43) PHM Comment

11.3 Amendments to the Financial Regulations and Financial Rules [if any]

12. Management and legal matters

12.1 Evaluation: update and proposed workplan for 2016–2017 (EB138/44) PHM Comment

12.2 Real estate: update on the Geneva buildings renovation strategy (EB138/45) PHM Comment

12.3 Process for the election of the Director-General of the World Health Organization (EB138/46) PHM Comment

12.4 Hosted health partnerships (EB138/47, EB138/47 Add.1, EB138/47 Add.2) PHM Comment

12.5 Reports of committees of the Executive Board

  • Standing Committee on Nongovernmental Organizations (EB138/48) PHM Comment

12.6 Provisional agenda of the Sixty-ninth World Health Assembly and date, place and draft provisional agenda of the 139th session of the Executive Board (EB138/50) PHM Comment

13. Staffing matters

13.1 Human resources: annual report (EB138/51 and EB138/51 Add.1) PHM Comment

13.2 Report of the International Civil Service Commission (EB138/52) PHM Comment

13.3 Amendments to the Staff Regulations and Staff Rules (EB138/54) PHM Comment

13.4 Statement by the representative of the WHO staff associations (EB138/INF./1) PHM Comment

14. Matters for information

14.1 Reports of advisory bodies: Expert committees and study groups (EB138/53, EB138/53 Add.1) PHM Comment

15. Closure of the session